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bstract
Mesenchymal stem cells (MSC) possess a wide range of immunosuppressive functions. Among these is the ability to inhibit CD4+ T cell prolif-
ration. Dendritic cells (DC) play a role in initiating cell-mediated immunity; however, the immunosuppressive influence of MSC on professional
ntigen presenting cells remains unclear. DC exposed to TNF- and cultured with murine MSC failed to show regular upregulation of maturation
arkers. Similarly, the presence of MSC abrogated the capacity of ovalbumin-pulsed DC to support antigen specific CD4+ T cell proliferation, or
or DC to display an MHC class II- peptide complex recognizable by specific antibody. Interestingly, culture of MSC with DC resulted in reduced
xpression of CCR7 by DC following stimulation. Likewise, DC matured in the presence of MSC, showed significantly less migration to CCL19.
n contrast, murine MSC prevented loss of expression of the tissue anchoring protein E-cadherin by DC. Modulation of DC maturation and function
as not permanent and could be restored after removal of MSC. These data demonstrate that MSC modulate the three cardinal features of DC
aturation, providing the first demonstration of MSC interference with DC migration.
2007 Elsevier B.V. All rights reserved.
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. Introduction
Adult mesenchymal stem cells (MSC) are multipotent cells
ble to self-renew under controlled conditions. MSC may differ-
ntiate into multiple lineages including bone, fat and cartilage
1,2]. Usually, MSC reside in the bone marrow, and provide
upport for hematopoietic stem cells through the production of
rowth factors [3]. However, the primary function of MSC is
o repair and replace damaged tissues [4–6]. These characteris-
ics make MSC an attractive source for tissue engineering and
egenerative medicine.
MSC possess an array of immunosuppressive capabilities.
arious groups have demonstrated that both murine and human
SC suppress alloantigen and mitogen driven T cell prolifera-ion in vitro [7–10]. Some of these functions are dependent on
xogenous IFN- [7,11,12]. Comparable studies, investigating
SC immunosuppression of B cells, have demonstrated that
∗ Corresponding author. Tel.: +353 1 708 3835; fax: +353 1 708 3845.
E-mail address: bpmahon@nuim.ie (B.P. Mahon).
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SC physically hindered proliferation [9,13], likewise, MSC
an inhibit NK cell proliferation and cytotoxicity [11,14]. Whilst
hese are important data, a deeper understanding of how MSC
odulate T cell responses will be central to the development of
cceptable therapies involving MSC.
Dendritic cells (DC) arise in the bone marrow and play a
ivotal role in the induction of adaptive immunity. DC have
he ability to initiate a primary adaptive immune response
hrough the capture, processing and presentation of antigen to
aı¨ve CD4+ T cells, however differences in these capacities
re linked to the developmental maturity of the DC. Imma-
ure DC (iDC), resident in tissue, efficiently capture antigen
15]. Exposure to stimuli such as pathogen associated molecules
ncluding LPS, bacterial DNA, or pro-inflammatory cytokines
e.g. TNF-), initiate a process termed maturation [16]. Matur-
ng DC alter the expression of chemokine receptors including
CR7, thus becoming responsive to the lymph node derived
hemokine CCL19 [17]. In addition, mature DC (mDC) down-
egulate E-cadherin expression, allowing migration to regional
ymph nodes [18]. In the lymph node, mDC express high levels
f MHC class II, CD80 and CD86 which play a well-described
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ole in antigen presentation to CD4+ T cells [15]. Thus, DC
aturation plays a key role in initiating T cell responses, and
ot surprisingly, many pathogens have exploited this process to
vade immunity [19,20].
A number of recent studies have focused on the influence of
SC on DC function [21–24]. However, data have been con-
ounded by differences in models, technical approaches and in
articular differences between MSC and DC isolation proto-
ols [21]. At least five different murine MSC populations have
een described and subtle differences in their function have been
bserved [10,13,25–27].
In the present study, a well-characterised MSC population
nd a clearly defined DC population were used to probe the inter-
ction between these two cell types. This study demonstrates
hat MSC disrupt the three major functions that characterise
he transition of DC from immature to mature stages; namely
he upregulation of antigen presentation and co-stimulatory
olecule expression, the ability to present defined antigens,
nd the capacity to migrate to CCL19. Collectively, these data
upport the hypothesis that MSC profoundly influence host
mmunity by modulating DC function suggesting that allogeneic
SC may not require profound immunosuppression during clin-
cal application.
. Materials and methods
.1. Animals
Six-to-eight-week-old female BALB/c (H-2d), C57BL/6
Harlan, Oxon, U.K.) and DO11.10 (H-2d) mice [28] were used
or experiments under the guidelines of the Irish Department of
ealth and the approval of the research ethics committee of the
ational University of Ireland Maynooth.
.2. Isolation and culture of bone marrow derived
esenchymal stem cells
Murine MSC were isolated and expanded using an in-house
odification [7] of the method of Peister et al. [29]. Cells
etained differentiation capacity as previously described [29].
ll MSC were MHC I+, Sca-1+, CD44low, CD106low, MHC
I−, CD11b−, CD11c−, CD34−, CD45− and CD117−. Stem
ells were used between passages 3 and 10 and rigorous purifi-
ation and quality control were performed to ensure MSC purity
s previously described [7].
.3. Dendritic cell culture
Isolation and culture of bone marrow derived DC was carried
ut as previously described with minor modifications [30,31].
riefly, immature DC were prepared by culturing cells taken
rom murine bone marrow (femur and tibia) in RPMI 1640
edium (Gibco-Invitrogen, Paisley, UK) supplemented with
0% (v/v) heat inactivated, endotoxin low fetal calf serum, 1%
v/v) penicillin/streptomycin (Gibco-Invitrogen) and 1% (v/v)
-glutamine (Gibco-Invitrogen) with either 95 ng/ml recombi-
c
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ant GMCSF/300 pg/ml IL-4 (Peprotech EC, London, UK) or
y recombinant J558 supernatant previously shown to be equiv-
lent in supporting DC culture [31]. Cells were cultured for
d at 37 ◦C, and culture medium was carefully replaced with
resh medium at this time. Cells were harvested at 6d by gentle
spiration, counted, and analysed by flow cytometry. DC popula-
ions used were >70% CD11c+ with no detectable expression of
ca-1, a marker found on MSC but not DC. In maturation experi-
ents, immature DC were seeded at 7.5 × 105/ml and cultured in
ml cRPMI +/− 25 ng/ml TNF-( (R&D systems, Abington, UK)
s maturing agent, then co-cultured in the presence or absence
f MSC or control MLE-12 cells (2.5 × 105/ml) for 24 h or 48 h.
ifferences in adherence to tissue culture plastic by the two pop-
lations allowed a simple but reproducible technique to recover
C from co-cultures. DC were harvested by gentle aspiration
rom strongly adherent MSC or MLE-12 cells after 24 or 48 h.
solated DC were re-analysed by flow cytometry using antibod-
es against CD11c and Sca-1. DC re-isolated by this method were
70% CD11c+ but did not express Sca-1 (<1%). For return of
unction studies, DC were similarly re-isolated from MSC co-
ulture and re-stimulated in fresh medium with TNF- for 48 h
efore use in chemotaxis assays.
.4. CD4+ T cell proliferation
Immature DC (1 × 105/ml) were cultured with 20g/ml
valbumin (Sigma–Aldrich) in the presence or absence of
SC (1:3 MSC: DC) for 24 h. DC were isolated by gen-
le aspiration, and washed twice in culture medium. DC
ere then co-cultured with 4 × 105/ml naı¨ve OVA-specific,
-Ad-restricted CD4+ DO11.10 T cells purified by negative
election (R&D Systems). Cells were cultured for 72 h in
otal with [3H]thymidine (Amersham Biosciences, Bucking-
amshire, England) (5Ci/ml) added for the final 6 h as
reviously described [32]. Cells were harvested and Thymidine
ncorporation quantified as mean counts per minute (±S.E.) by
iquid scintillation [32].
.5. Flow cytometry
Cell phenotype was characterised by flow cytometry (FAC-
Calibur), analysed using CellQuest software (BD Biosciences,
xford, UK). Cells were labelled with combinations of FITC or
E-conjugated antibodies against Sca-1, CD11b, CD11c, CD34,
D40, CD44, CD45, CD80, CD86, CD106, CD117, CCR7,
HC I and II or appropriate species and isotype-matched con-
rols (eBiosciences, San Diego, CA).
.6. Chemotaxis
Cell migration was performed in 24-well TranswellTM cham-
ers (Corning Costar, Cambridge, MA) using 5m-pore size
olycarbonate membranes as described [33] with minor modifi-
ations. 1 × 105 mature DC in serum free medium (100l) were
oaded into the upper chamber. CCL19 (100 ng/ml) (R & D Sys-
ems) in sterile serum-free RPMI, 1% (v/v) BSA was added to the
ower chamber. After 1.5 h incubation at 37 ◦C, 5% CO2, chemo-
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axed cells were counted in three random fields of view from
igital images generated using an inverted microscope (Olym-
us CK40, Centre valley, PA). Each assay was performed in
uplicate, and repeated three times. The lower compartment of
ontrol wells contained medium alone. A chemotactic index was
alculated against the basal level of DC migration to medium
lone.
.7. Eα:I-Ab MHC class II complex antigen presentation
ssay
DC were incubated alone or in the presence of 10g/ml
-E peptide 52–68 (ASFEAQGALANIAVDKA) (Anaspec,
an Jose, CA) or vehicle buffer control in the presence or
bsence of MSC for 48 h. Peptide binding was detected using
he biotin-conjugated anti-I-Ab:E complex-specific antibody,
Ae (eBioscience) as previously described [34]. Binding of
iotin-conjugated antibody was detected by PE-conjugated
treptavadin (Sigma–Aldrich) and was analysed by flow cytom-
try (BD Biosciences). Data analysis was carried out using
ellQuest software (BD Biosciences).
.8. Semi-quantitative RT-PCR
DC were seeded at 6 × 105 cells/ml in 24-well cultures
Nunc, Rorsklide, Denmark) and either non-stimulated, or
atured with TNF- (25 ng/ml) in the presence, or absence
f MSC (2 × 105/ml) and harvested at 24 h for RNA isolation
sing TRI ReagentTM (Molecular Research Centre, Cincinnati,
H) according to manufacturer’s instructions. cDNA from iDC,
DC or DC cultured with MSC were probed for GAPDH,
CR7 or E-cadherin. Primers pairs were: GAPDH: 5′-GGTG-
AGGTCGGAGTCAACG-′3 and 5′-CAAAGTTGTCATGG-
TGACC-′3; E-cadherin: 5′-GGCTGGACCGAGAGAGTT-′3
nd 5′-CTGCTTGGCCTCAAAATC-′3; CCR7: 5′-AGTCTT-
CAGCTGCCCTACA-′3 and 5′-CAGCCCAAGTCCTTGAA-
AG-′3.
.9. Quantitative RT-PCR
cDNA were analysed for the expression of murine CCR7
nd E-cadherin by fluorogenic 5′- nuclease PCR assay (MJ
esearch Inc., Waltham, MA). cDNA (500 ng) were amplified
n the presence of SYBR® Green PCR mastermix (Qiagen, West
ussex, UK). Standard curves for CCR7 and E-cadherin expres-
ion were generated by amplifying 10-fold serial dilutions of
nown quantities of CCR7 and E-cadherin PCR product stan-
ards. Quantification of target gene expression was obtained
sing sequence detector system software (MJ Research Inc.,
altham, MA).
.10. Western blotCells were lysed in RIPA buffer (Sigma–Aldrich) and
ysate resolved by 12% SDS/PAGE, then electro-transferred
o nitrocellulose membranes (Amersham Biosciences, Buck-
nghamshire, U.K.) and blocked for 1h in 5% (w/v) non-fat
i
r
o
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ilk powder/PBS with 0.05% (v/v) Tween 20. Membranes were
robed with anti-mouse E-cadherin (BD Biosciences, Oxford,
K) or matched control antibody. Binding of antibody to E-
adherin was detected by horseradish peroxidase conjugated
nti-mouse secondary antibody (Sigma–Aldrich) and detected
y Amersham ECL Western Blotting analysis system (Amer-
ham Biosciences).
.11. Statistical methods
Results are expressed as mean ± (S.E.). A Student’s paired
-test was used to determine significance between the groups,
< 0.05 was considered significant. Statistical analyses and
raphical representations were performed using GraphPad
rismTM software (GraphPad, San Diego, CA).
. Results
.1. Murine MSC prevent TNF-α driven dendritic cell
aturation
DC maturation is a critical feature for the induction of adap-
ive immune responses, aspects of alloantigen elimination and
ransplant rejection. Maturation is accompanied by phenotypic
hanges in DC surface protein expression associated with APC
ompetence. The capacity of MSC to modulate DC maturation
riven by a robust stimulus was examined. Immature bone mar-
ow derived CD11c+ DC (iDC) expressed low levels of MHC
lass II and the co-stimulatory molecule CD86 (Fig. 1A), as
xpected, maturation by TNF- resulted in increased surface
xpression of these markers (Fig. 1A). DC are susceptible to
aturation by relatively gentle manipulation, importantly co-
ulture of immature DC with MSC did not lead to increased
xpression of CD86 or MHC class II, and therefore manipulation
r contact between these cell types did not result in anoma-
ous DC maturation. DC cultured with TNF- were separated
rom strongly adherent MSC in co-cultures by gentle aspiration
fter 48 h. Unlike DC exposed to TNF- alone, DC cultured
ith TNF- in the presence of MSC failed to upregulate either
arker post TNF- stimulation (Fig. 1A), rather DC co-cultured
ith MSC showed significantly reduced surface expression of
HC class II and CD86 (Fig. 1B). It was possible that co-culture
f DC with MSC led to exhaustion of nutrients in cell culture
edium. Therefore it might be argued that MSC modulation of
C maturation marker expression was not MSC specific and/or
as merely a result of nutrient exhaustion in the culture medium.
o rule out this possibility, co-cultures were repeated in which
apidly dividing transformed epithelial cells (MLE-12) replaced
SC. Co-culture of DC with MLE-12 cells did not prevent
pregulation of MHC class II or CD86 suggesting that com-
etition for nutrients or medium exhaustion was unlikely to be
he mechanism of modulation (Table 1.). The presence of MSC
n cultures did not increase DC apoptosis or alter cell viabil-
ty. Furthermore DC removed from co-culture with MSC and
e-stimulated with TNF- for 48 h showed regular upregulation
f maturation markers as indicated by MHC class II (Fig. 1C).
hese data are consistent with the hypothesis that MSC induce
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Fig. 1. Murine MSC prevent upregulation of DC maturation markers. Immature DC (iDC) were stimulated with TNF- (mDC) and cultured in the presence or absence
of MSC for 48 h. DC stimulated with TNF- were separated from adherent MSC in co-cultures by gentle aspiration after 48 h and maturation marker (MHC class II
or CD86) expression (shaded) analysed by flow cytometry and compared to species and isotype-matched controls (open). Data were expressed as histograms (A) or
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o could
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iean fluorescence intensity (MFI) change (B). DC cultured with MSC showed s
reviously co-cultured with MSC, were harvested from MSC co-cultures, re-sti
f MHC class II. (C). Expression of MHC class II by DC in response to TNF-
n= 3), from a minimum of three experiments. Cells remained viable throughout
r maintain DC with an immature or “suppressor” phenotype,
ut this condition is not permanent and regular DC maturation
an be restored in the absence of MSC (Fig. 1C).
.2. Murine MSC interfere with dendritic cell antigen
resentation
DC maturation involves a switch from antigen acquisition to
ntigen processing and presentation, a process that is broader
p
b
(
ecantly reduced MHC class II MFI (***, p< 0.001), and CD86 (*, p< 0.05). DC
ed with TNF- and examined for the capacity to upregulate surface expression
be restored if MSC were removed. Results are mean (±S.E.) of triplicate data
re and no induction of apoptosis was detected in this or subsequent experiments.
han merely MHC class II, and CD86 upregulation. Interfer-
nce in this process is likely to hamper antigen presentation,
ince co-stimulatory molecules are essential for optimal antigen
resentation to naive CD4+ T cells. In order to investigate the
nfluence of MSC on antigen presentation, an antigen-specific
roliferation assay was performed using DO11.10 CD4+ T cells
earing the transgenic T cell receptor specific for the ovalbumin
OVA) peptide 323–339. This model was chosen to allow defined
pitope effects to be studied and to avoid confounding effects
54 K. English et al. / Immunology
Table 1
MSC but not transformed epithelial cells prevent DC upregulation of maturation
markers
Marker Expression (mean fluorescence intensity)a
iDC mDC mDC + MSC mDC + MLE
CD11c 48 63 69 52
MHC II 539 601 410 990
CD86 44 68 46 78
a CD11c, MHC class II and CD86 expression were measured by flow cytom-
etry of iDC, mDC, and TNF-a stimulated DC co-cultured with either MSC
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rmDC+MSC) or the transformed epithelial cell line MLE-12 (mDC+MLE). Data
re presented as mean fluorescent intensity from a representative experiment of
hree replicates, 10,000 events were sampled in each case.
f allogenicity possible in other systems. Whole OVA pulsed
C derived from non-transgenic haploidentical bone marrow,
fficiently supported antigen-specific DO11.10 CD4+ T cell pro-
iferation (Fig. 2A). However, when DC were cultured in the
resence of antigen and MSC, CD4+ T cell proliferation was
artially but significantly reduced (Fig. 2A). The use of whole
VA protein, as opposed to specific peptide in these studies indi-
ated that full antigen processing is occurring and eliminated the
ossibility of auto-presentation of peptide in a T cell to T cell
anner.
T cell proliferation is a complex system and reductions might
e occurring through other mechanisms. The effect of MSC on
pecific antigen presentation by DC was therefore analysed by
well-defined antigen presentation system taking advantage of
he YAe antibody [35]. This antibody recognises a complex com-
c
e
p

ig. 2. MSC interfered with DC antigen presentation. Immature DC pulsed with OVA
efore culture with CD4+ DO11.10 T cells (A). After 72 h, [3H]thymidine incorporat
o support D011.10 CD4+ T cell proliferation (***, p< 0.001). Results are mean (±
resentation was also measured using an alternative display system (B). iDC alone or
r absence of MSC for 48 h were harvested as described in Fig. 1. Labelling by biotin
educed DC presentation of I-E:I-Ab MHC class II peptide complex detected by ofLetters 115 (2008) 50–58
osed of I-E peptide bound to I-Ab MHC class II molecules.
57/BL6 DC were chosen for these studies because this strain
xpress I-Ab but not I-E and therefore would not constitutively
xpress the I-E: I-Ab MHC class II complex [36]. C57/BL6
C pulsed with I-E peptide displayed the peptide: MHC II
omplex at the cell surface as determined by recognition of the
uorescently labelled YAe antibody (Fig. 2B). However, this was
educed when DC had been co-cultured with MSC (Fig. 2B),
hereas controls consisting of iDC alone or iDC pulsed with
ehicle buffer in the presence of MSC did not display the pep-
ide: MHC II complex. Taken together these data confirm a role
or MSC interference in antigen presentation by DC.
.3. Murine MSC prevent dendritic cell migration ability to
CL19
DC maturation is accompanied by an alteration in the expres-
ion of chemokine receptors and other surface markers reflecting
he requirement of maturing DC to migrate to regional lymph
odes. The three most striking of these alterations are: (1) the
cquisition of CCR7 surface expression by mature DC; (2) a con-
equent capacity to migrate to CCL19 not seen in immature DC
17]; and (3) the loss of expression of the epithelial anchoring
rotein E-cadherin. Consequently, the effect of MSC on CCR7
xpression and chemotactic ability by DC was investigated. DC
ultured in the presence of MSC and stimulated with TNF-
xhibited reduced CCR7 mRNA (Fig. 3A), and reduced surface
rotein expression (Fig. 3B) when compared to regular TNF-
matured DC. Similarly, an examination of the chemotactic
in the presence or absence of MSC for 24 h were harvested and washed twice
ion was measured. MSC significantly decreased the ability of OVA pulsed DC
S.E.) of triplicate data (n= 3), from a minimum of three experiments. Antigen
iDC pulsed with E peptide (10g/ml) or vehicle buffer control in the presence
ylated YAe, coupled to streptavidin-PE was detected by flow cytometry. MSC
YAe. Results are representative of two replicates in this instance.
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Fig. 3. Murine MSC downregulated CCR7 mRNA and surface protein expression by mature DC. (A) CCR7 mRNA was determined by quantitative real time RT-PCR
at 24 h from immature DC or TNF- stimulated DC cultured in the presence or absence of MSC. CCR7 mRNA expression by stimulated DC was significantly lower
w timulated DC (mDC) or mDC cultured with MSC (mDC + MSC) was examined by
fl CR7 surface expression by TNF- matured DC at 48 h. Results are mean (±S.E.) of
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Fig. 4. Murine MSC interfered with DC migration toward CCL19. The abil-
ity of DC matured with TNF- in the presence or absence of MSC for 48 h to
migrate toward CCL19 was examined (A). TNF- stimulated DC co-cultured
in the presence of MSC displayed a significantly reduced chemotactic response
to CCL19 compared to mature DC alone (**, p< 0.01). Chemotactic ability
was not permanently compromised (B). DC previously co-cultured with MSC,
removed from MSC co-cultures and re-stimulated with TNF- for 48 h migratedhen cultured with MSC (*, p< 0.05). (B) CCR7 expression by iDC, TNF- s
ow cytometry with isotype-matched controls for comparison. MSC reduced C
riplicate data (n= 3), from a minimum of three experiments.
esponse revealed that DC co-cultured with MSC displayed sig-
ificantly reduced capacity to migrate to CCL19, the lymph node
xpressed chemokine ligand for CCR7 (Fig. 4A). This reduction
as not permanent, as removal of the DC from MSC co-cultures
nd subsequent re-stimulation with TNF- restored the capacity
f DC to migrate to CCL19 (Fig. 4B) and again confirmed that
hese were not affects attributable to medium exhaustion.
For effective relocation, mature DC must not only become
esponsive to lymph node derived signals, but must also
ownregulate tissue anchoring proteins [18,37,38]. The most
rominent of such proteins is E-cadherin. E-cadherin has been
eported to play an important role in interactions between
mmature Langerhans cells and skin tissue [18,37,38]. Upon
aturation, Langerhans cells downregulate the anchor protein
-cadherin in order to migrate to the local lymph node [38].
he influence of MSC on E-cadherin was therefore examined.
n co-culture experiments, MSC prevented downregulation of
-cadherin mRNA expression in TNF- stimulated DC, as
easured by semi-quantitative and quantitative real time PCR
Fig. 5A and B). This was reflected in E-cadherin protein expres-
ion, as detected by immunoblot, which was similar to that
f immature DC and greater than that observed in mature DC
Fig. 5C). Taken together these data indicate that MSC influence
C maturation to prevent loss of tissue anchor proteins and limit
cquisition of responsiveness to lymph node derived signals.
. Discussion
This study demonstrates that MSC interfered with the three
ardinal aspects of DC maturation. DC matured with TNF-
nd cultured in the presence of MSC failed to show upregula-
ion of the maturation marker CD86 and did not increase MHC
lass II surface expression. Furthermore, MSC suppressed the
apacity of DC to support antigen specific proliferation by T
ells and interfered with the display of specific peptide:MHC
omplex by DC as measured using the E presentation system.
n addition this study demonstrated for the first time that MSC
reserve DC expression of tissue anchoring proteins, prevent
towards CCL19. Data are expressed as chemotactic index calculated against the
basal level of mature DC migration to medium alone. Results are mean (±S.E.)
of counts determined from three random fields of view in duplicate chambers
(n= 2), data shown is representative from a minimum of three independent
experiments.
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Fig. 5. Murine MSC prevented E-cadherin downregulation by TNF- stimulated DC. (A) E-cadherin mRNA was measured by semi quantitative PCR of immature
DC, mature DC or mature DC cultured in the presence of MSC at 24 h. (B) Quantitative real time RT-PCR also showed that E-cadherin mRNA expression was
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ceduced in mature DC (*, p< 0.05), but not by mature DC cultured in the presen
f MSC detected by immunoblot was similar to that of immature DC. Data from
epresentative of a minimum of three experiments.
CR7 chemokine receptor expression and reduce the migration
apacity of DC to lymph node derived chemokines.
Modulation or prevention of DC maturation is a well-
escribed observation but remains poorly characterised. It is
nown that immature or so-called “semi-mature” DC have
mmunosuppressive or regulatory characteristics. This has been
est characterised in infectious disease models. For example,
nfluenza virus hemagglutinin (HA) and a virulence factor from
ordetella pertussis filamentous hemagglutinin (FHA) have
een shown to modulate DC maturation marker expression
19,20] reduce IL-12 production [20] and induce IL-10 induction
19]. The present study using TNF- driven maturation, studies
y Nauta et al. [22] using CD40L and especially those of Djouad
t al. [39] using LPS clearly demonstrate that MSC influence
C to maintain or adopt a similar phenotype. This is consistent
ith previous studies that have demonstrated that MSC constitu-
ively express TGF-1, and HGF [7,8,40] and with our previous
emonstration that IFN- enhanced MSC immunomodulation
7,12]. The present study suggests that MSC maintain DC with
n immature or “semi-mature” suppressor phenotype [38] which
ontributes to the immunosuppressive capacity of MSC.
The mechanisms of MSC modulation of DC maturation have
et to be elucidated fully. However, studies by Djouad et al.
39] have demonstrated a role for IL-6 in MSC modulation of
aturation marker expression. A possible role for IL-6 had also
een alluded to by Nauta et al. [22] in 2006. Similar neutrali-
ation studies in our system confirmed that MSC derived IL-6,
ut not HGF or TGF-1 prevented upregulation of DC matura-
ion marker expression (data not shown). These data concerning
SC modulation of DC are in contrast to MSC modulation of
llo-antigen driven responses measured in MLR which are medi-
ted by MSC derived PGE-2 and in some circumstances by
ndoleamine 2,3, dioxygenase expression [7,12,41–43]. Thus,
SC modulate diverse aspects of the adaptive immune response
hrough multiple different mechanisms.
In addition to modulation of DC maturation markers, MSC
nterfered with DC antigen presentation ability as demonstrated
ere using an antigen specific T cell proliferation assay and
pecific peptide:MHC II antigen display. Although MSC signifi-
antly interfered with DC presentation of ovalbumin to DO11.10
D4+ T cells, the inhibition of antigen presentation was only
C
C
a
tMSC. (C) E-cadherin protein expression in mature DC cultured in the presence
titative PCR is presented as mean (±S.E.) of triplicate data (n= 3). All data are
artial. There are a number of possible explanations for this.
t may be that a monoclonal DO11.10 CD4+ T cell response
o ovalbumin presented by DC is less susceptible to suppres-
ion than polyclonal or wildtype populations, or that multiple
echanisms contribute to overall suppression and reduction and
ntigen display is only one contributory factor. In studies by
iang et al. focusing on monocyte to DC differentiation, human
llogeneic MSC were shown to hamper antigen presentation
y DC in a keyhole-limpet hemocyanin (KLH) antigen spe-
ific T cell model. Allogeneic MSC downregulated both antigen
resentation and IL-12 expression by DC [21]. Although the
O11.10 system used here might be less susceptible to immuno-
uppression by MSC, the use of a well-defined antigen and
ransgenic T cell model avoided the potentially confounding
ffect of allogenicity. Furthermore, the use of whole OVA pro-
ein, as opposed to specific peptide, indicated that full antigen
rocessing is occurring rather than “bystander” presentation of
eptide in a T cell to T cell manner. Nevertheless T cell prolifer-
tion is a complex interaction and may not be a straightforward
arker of APC activity, therefore the E antigen display system
as employed to confirm that Ag-peptide display at the DC sur-
ace was reduced by MSC co-culture. These findings and those
f Jiang et al. [21] lead to the conclusion that MSC reduce the
PC function of DC and that this is not related to allogenicity,
ut involves modulation of DC antigen presentation machinery.
DC ability to migrate to the local lymph nodes and the sub-
equent presentation of antigen to T cells play an essential role
n initiation of adaptive immunity [44]. In tissues, mature DC
ust become responsive to lymph node derived signals, but must
lso downregulate tissue anchoring proteins such as E-cadherin
18,37,38] that would otherwise veto DC migration and anti-
en presentation to naı¨ve T cells. This study provided the first
ndication that this process is modulated by MSC, such that DC
xposed to TNF- failed to downregulate E-cadherin. Likewise,
he expression of the chemokine receptor CCR7 by mature DC
lays an important role in DC migration to lymph node derived
hemokines such as CCL19. MSC significantly reduced both
CR7 surface expression by DC and the functional migration to
CL19. Together, these data show that MSC interfered with key
spects of DC migration. The implications of these findings are
hat sites of repair where MSC are present (or tissues targeted
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n regenerative medicine) should either display an accumulation
f immature DC, or reduce DC recruitment to draining lymph
odes. We are currently examining that question, but intrigu-
ngly it suggests that MSC may have an additional application
s an immunosuppressive therapy in autoimmune disease.
The ability of MSC to suppress alloreactivity has now been
haracterised by a number of groups [7–10], however, the need
or MSC to possess this activity has been perplexing. The influ-
nce of MSC on DC shown here may partially resolve this
roblem. Firstly, both immature DC and MSC are normally res-
dent in the bone marrow. The capacity for MSC to veto DC
unction would help impede premature maturation of DC, prior
o DC exit from the bone marrow. Secondly, the main role of
dult MSC is in tissue repair. This process is de facto part of the
esolution phase that follows physiological or microbial insult.
herefore, whilst DC maturation needs to be promoted during
nflammatory events, MSC mediated resolution would favour a
on-inflammatory environment and preservation of DC imma-
urity. The ability of MSC to modulate the three major aspects of
C maturation shown herein is consistent with that hypothesis.
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